DXCM
DexCom, Inc. · Healthcare · Medical Devices
TECHSellZACKSHold
R500#420 today
$85.36
-1.01% today · -1.45% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- DXCM −1.01% on the last session vs SPY +0.74%: −1.7 pts of stock-specific move.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Insiders · 1 month
none
no open-market trades
Insiders · 3 months
none
no open-market trades
Congress · 3 months
none
no reported trades
Congress · 1 year
≈−$342K
1 buy · 2 sells · 2 members
Insiders
No insider buys or sales on record for DXCM.
Officers, directors and 10% owners file SEC Form 4 within two business days. Unplanned: the insider chose to trade now, the trades worth attention; their dollars make the net above. 10b5-1 plan: scheduled in advance, kept for the record. Tax: shares withheld on vesting stock, not a market trade. Awards, option exercises and gifts are left out. Source: SEC EDGAR, collected daily for the stocks discussed on Reddit.
Congress
| Trade date | Member | Chamber | Side | Amount | Disclosed |
|---|---|---|---|---|---|
| May 7, 2026 | Tina Smith | Senate | Sell | $100K–$250K | May 10 |
| Apr 29, 2026 | Tina Smith | Senate | Sell | $100K–$250K | May 10 |
| Jan 26, 2026 | John Boozman | Senate | Buy | $1K–$15K | Feb 15 |
Members of Congress report trades within 45 days of the trade date, so these are never real-time. Amounts are disclosed as ranges; the net uses each range's midpoint (≈). Source: House and Senate periodic transaction reports via CongressInvests, refreshed daily. All recent insider and congressional trades